A study by Larsen et al. [97] demonstrated that in colorectal cancers, deficiency of MLH1/PMS2 in the primary tumor tissue is correlated with an MLH1/PMS2 proficiency in the associated liver metastases. Here, PMS2 is linked to neoplasm.